Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018）

Status:
Not yet recruiting

Trial end date:
2024-06-18

Target enrollment:

Participant gender:

This trial is a multi-center, open, single-arm, superior phase II clinical study.

Phase 2

Guoxin Li